Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Stock-based compensation changed +101.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Trade receivables changed +26.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Free-cash-flow proxy changed -230.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
Operating cash flow changed -228.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
Cash & equivalents changed -34.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Current liabilities changed +12.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed -2052 basis points from the comparable as-filed period.
Gross margin changed -901 basis points from the comparable as-filed period.
Working capital / assets changed -635 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Working capital changed -29.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Receivables / revenue changed +1456 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Cost of revenue changed +37.6% from the comparable as-filed period.
Operating income changed -234.1% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Capital expenditure changed -53.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Net income changed -252.4% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Free-cash-flow margin changed -1258 basis points from the comparable as-filed period.
Operating cash-flow margin changed -1260 basis points from the comparable as-filed period.
Research & development changed -13.8% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Gross profit changed -14.1% from the comparable as-filed period.
Shares outstanding changed -7.1% from the comparable as-filed period. The change ranks at the 14th percentile of 7 prior comparable changes.
Revenue changed -2.9% from the comparable as-filed period.
SBC / revenue changed +153 basis points from the comparable as-filed period.
Current ratio changed -7.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Capex / revenue changed -3 basis points from the comparable as-filed period.
Current assets changed +4.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Total assets changed +2.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
R&D / revenue changed -33 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.